The Cancer Letter

Inside information on cancer research and drug development

Vol.
31
No.
3
March 28, 2008Mar 28, 2008
Free
DOWNLOAD THE PDF

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy

BMI May Be Prognostic Tool For Types Of Breast Cancer

Postoperative Chemo Doesn’t Improve Survival, Study Finds

Risks Of Long-Term HRT Outweigh Benefits, WHI Finds

Cause Of Allergic Reaction To Cetuximab Found

NCI Cooperative Group, Cancer Center Trials Listed

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account